Literature DB >> 24566601

Prevention of cardiovascular disease: updating the immensity of the challenge and the role of risk factors.

Richard Kones1, Umme Rumana.   

Abstract

Despite remarkable decreases in the mortality of coronary heart disease, there is concern that continued high levels of cardiovascular risk in the population may reverse these gains. By 2015, the prevalence of cardiovascular disease in the United States will be 37.8%. Obesity, hypertension, dyslipidemia, diabetes mellitus (DM), metabolic syndrome, and inflammation are the primary components driving cardiovascular risk. Approximately 70% of adults are overweight or obese, yet diet quality continues to deteriorate and authoritative information is insufficiently promoted. More than half of US adults have lipid abnormalities; 27% of US adults have high values of low-density lipoprotein cholesterol, 23% have low values of high-density lipoprotein cholesterol concentrations, and 30% have high triglyceride levels. Approximately 34% of adults have hypertension; 40% of these adults are unaware of the diagnosis. In patients with hypertension who are treated, 54% remain uncontrolled. The prevalence of hypertension in elderly patients has increased from 35% to 41%. In addition, 30% of adults have prehypertension. The burden of hypertension alone accounts for approximately 1000 deaths per day. Trends in the prevalence of glucose intolerance are similar. The prevalence of DM is approximately 12%, with 27% of cases remaining undiagnosed. Thirty-five percent of US adults aged > 20 years have prediabetes and 7.3% of adults are unaware of the diagnosis. If the present trends continue, 1 in 3 of US adults will have DM by 2050. Participation in exercise has been low and a "straight line" for > 2 decades. Accelerometer data indicate that individuals who attain minimal exercise goals are only a fraction of the often quoted levels of > 35%. Control of risk factors in primary prevention, although improved, remains decidedly incomplete. Lowering the burden of cardiovascular risk factors at the population level has been exceptionally difficult. For reasons outlined, the solution to this problem is multifaceted and extends well beyond the delivery of medical care into the structure of society and the environment.

Entities:  

Mesh:

Year:  2014        PMID: 24566601     DOI: 10.3810/hp.2014.02.1096

Source DB:  PubMed          Journal:  Hosp Pract (1995)        ISSN: 2154-8331


  10 in total

1.  Therapy: Caloric and fat intake in statin users.

Authors:  Vasilios G Athyros; Dimitri P Mikhailidis
Journal:  Nat Rev Endocrinol       Date:  2014-06-03       Impact factor: 43.330

2.  Determinants of nephrostomy tube dislodgment after percutaneous nephrolithotomy.

Authors:  David Bayne; Eric R Taylor; Lindsay Hampson; Thomas Chi; Marshall L Stoller
Journal:  J Endourol       Date:  2014-12-17       Impact factor: 2.942

3.  Induced peroxidase and cytoprotective enzyme expressions support adaptation of HUVECs to sustain subsequent H2O2 exposure.

Authors:  Hemang Patel; Juan Chen; Mahendra Kavdia
Journal:  Microvasc Res       Date:  2015-09-25       Impact factor: 3.514

Review 4.  Immune regulators of inflammation in obesity-associated type 2 diabetes and coronary artery disease.

Authors:  Katherine J Strissel; Gerald V Denis; Barbara S Nikolajczyk
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

5.  Awareness, treatment and control of cardiometabolic disorders in Chinese adults with diabetes: a national representative population study.

Authors:  Tiange Wang; Yu Xu; Min Xu; Weiqing Wang; Yufang Bi; Jieli Lu; Meng Dai; Di Zhang; Lin Ding; Baihui Xu; Jichao Sun; Wenhua Zhao; Yong Jiang; Limin Wang; Yichong Li; Mei Zhang; Shenghan Lai; Linhong Wang; Guang Ning
Journal:  Cardiovasc Diabetol       Date:  2015-02-26       Impact factor: 9.951

6.  Short-term effects of a combined nutraceutical of insulin-sensitivity, lipid level and indexes of liver steatosis: a double-blind, randomized, cross-over clinical trial.

Authors:  Arrigo F G Cicero; Martina Rosticci; Angelo Parini; Martino Morbini; Riccardo Urso; Elisa Grandi; Claudio Borghi
Journal:  Nutr J       Date:  2015-03-28       Impact factor: 3.271

Review 7.  Effects of Vegetables on Cardiovascular Diseases and Related Mechanisms.

Authors:  Guo-Yi Tang; Xiao Meng; Ya Li; Cai-Ning Zhao; Qing Liu; Hua-Bin Li
Journal:  Nutrients       Date:  2017-08-10       Impact factor: 5.717

8.  Inflammatory signatures distinguish metabolic health in African American women with obesity.

Authors:  Gerald V Denis; Paola Sebastiani; Kimberly A Bertrand; Katherine J Strissel; Anna H Tran; Jaromir Slama; Nilton D Medina; Guillaume Andrieu; Julie R Palmer
Journal:  PLoS One       Date:  2018-05-08       Impact factor: 3.240

9.  Why is the gender gap in life expectancy decreasing? The impact of age- and cause-specific mortality in Sweden 1997-2014.

Authors:  Louise Sundberg; Neda Agahi; Johan Fritzell; Stefan Fors
Journal:  Int J Public Health       Date:  2018-04-13       Impact factor: 3.380

10.  Factors Associated with Excessive Body Fat in Men and Women: Cross-Sectional Data from Black South Africans Living in a Rural Community and an Urban Township.

Authors:  Kufre Joseph Okop; Naomi Levitt; Thandi Puoane
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.